|
|
Volumn 10, Issue 8, 1999, Pages 877-882
|
|
Advanced colorectal cancer: Which regimes should we recommend?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CAPECITABINE;
DEXAMETHASONE;
FLOXURIDINE;
FLUOROPYRIMIDINE DERIVATIVE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
METHOTREXATE;
OXALIPLATIN;
POLYGLUTAMIC ACID;
RALTITREXED;
TEGAFUR;
THYMIDYLATE SYNTHASE INHIBITOR;
URACIL DERIVATIVE;
BLOOD TOXICITY;
BOLUS INJECTION;
CANCER COMBINATION CHEMOTHERAPY;
COLORECTAL CANCER;
CONTINUOUS INFUSION;
EDITORIAL;
GASTROINTESTINAL TOXICITY;
HEPATIC ARTERY;
HUMAN;
INTRAARTERIAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER METASTASIS;
ORAL DRUG ADMINISTRATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ANTIMETABOLITES, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
COLORECTAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
INFUSIONS, INTRA-ARTERIAL;
INFUSIONS, INTRAVENOUS;
LIVER NEOPLASMS;
MALE;
PROGNOSIS;
SEVERITY OF ILLNESS INDEX;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
|
|
EID: 0032859967
PISSN: 09237534
EISSN: None
Source Type: Journal
DOI: 10.1023/A:1008348904180 Document Type: Editorial |
|
Times cited : (17)
|
|
References (24)
|
